Where To Next? Tigenix Investors Have New Stem Cell Options – Seeking Alpha
Seeking Alpha |
Where To Next? Tigenix Investors Have New Stem Cell Options
Seeking Alpha After our recent article on Tigenix (TIG) in which we postulated that their Phase III success in treating Crohn's related fistulas with stem cell therapeutic Alofisel would result in EU marketing approval we have seen a flurry of excitement in the … |
